SBIR/STTR Research Award

GENOTYPING WITH MINOR-GROOVE-BINDER-CONTAINING PROBES.

Award identifier d57c28d07f929b16330cfaed89cbe4e339f01e161fd58e6031d5c6dcdda9d0beAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$429,784

Program and phase

SBIR · Phase II

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
EPOCH BIOSCIENCES, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

APPLICANT'S DESCRIPTION: DNA fingerprinting, or profiling, is widely used for paternity cases and criminal investigations (forensics). Current methodologies are cumbersome, expensive and often fail to produce interpretable results. A minor groove binder (MGB) has been developed that greatly enhances the ability of oligonucleotide probes to discriminate single nucleotide polymorphisms (SNPs) in the 5' nuclease (Taqman (registered), real time PCR, fluorescence quench release) assay. The goal is to develop a kit for rapid high throughput DNA fingerprinting using probes that contain MGB's and other proprietary modifications. The fingerprint is derived from a panel of 23 diallelic polymorphisms. The probability that two unrelated individuals would have matching fingerprints is approximately 1 in 10 (exp) 8. In the Phase I effort, PCR primers and probes for the 23 loci were optimized and their function was demonstrated in 5' nuclease assays using a set of known DNA samples. The goal of phase II is to develop a commercial prototype with increased throughput and reduced cost. Application of four spectrally separated reporter fluorophores and a novel quencher will enable multiplexed assays. Standard affordable instruments will replace expensive instruments specialized for 5' nuclease assays. The technologies developed herein can be readily applied to assays of any SNP's. Huge potential markets exist for these technologies in clinical diagnostics and pharmacogenomics. PROPOSED COMMERCIAL APPLICATION: The commercial prototype presented here is a kit for human identification in paternity testing. The technologies developed herein for single nucleotide polymorphism (SNP) screening could have wide market potentials in a variety of applications including clinical diagnostics and pharmacogenomics.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.